Santen EMEA and NTC are delighted to announce that the results of their phase III clinical study, LEADER7, have been published in Eye. The study demonstrated for the ...

The aim with the dexamethasone program is to create a product that is used once a day. (Bruno Henrique/Pixabay) Optifye Therapeutics has struck a deal with DelSiTech for controlled-release ...

Although dropless cataract surgery techniques eliminate the need for eye drops, these are still a standard part of traditional cataract surgery recovery. They help prevent complications, control pain, ...

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (Nasdaq: OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for ...

Please provide your email address to receive an email when new articles are posted on . NEW ORLEANS — Using Dextenza as a postoperative steroid treatment after cataract surgery saved practices about ...

To compare outcomes of cataract surgery combined with either anti-Vascular Endothelial Growth Factor (anti-VEGF) therapy or dexamethasone implant (DEX) in patients with diabetic macular oedema (DMO).

BEDFORD, Mass.--(BUSINESS WIRE)--Ocular Therapeutix, Inc. (NASDAQ:OCUL), a biopharmaceutical company focused on the formulation, development, and commercialization of innovative therapies for diseases ...

The Nature Index 2026 Research Leaders reveal the leading institutions and countries/territories in the natural sciences, health sciences, applied sciences and social sciences, according to their ...